BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.880
+0.020 (1.08%)
Aug 14, 2025, 1:55 PM - Market open

BioCardia Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
-8.79-7.95-11.57-11.91-12.62-15
Upgrade
Depreciation & Amortization
0.050.070.080.080.060.07
Upgrade
Loss (Gain) From Sale of Assets
--0-0.02-
Upgrade
Stock-Based Compensation
0.620.741.031.181.662.95
Upgrade
Provision & Write-off of Bad Debts
--0.030.02---
Upgrade
Other Operating Activities
0.380.360.330.30.58-0.51
Upgrade
Change in Accounts Receivable
-0.10.12-0.050.09-0.09
Upgrade
Change in Inventory
-----0
Upgrade
Change in Accounts Payable
-0.14-0.320.180-0.24-0.17
Upgrade
Change in Unearned Revenue
---0.34-0.510.16-0.01
Upgrade
Change in Other Net Operating Assets
-0.57-10.170.34-0.070.39
Upgrade
Operating Cash Flow
-8.45-8.03-9.97-10.56-10.37-12.36
Upgrade
Capital Expenditures
-0-0.01-0.01-0.07-0.12-0.03
Upgrade
Investing Cash Flow
-0-0.01-0.01-0.07-0.12-0.03
Upgrade
Long-Term Debt Issued
-----0.51
Upgrade
Total Debt Issued
-----0.51
Upgrade
Net Debt Issued (Repaid)
-----0.51
Upgrade
Issuance of Common Stock
9.1410.554.395.542.0130.5
Upgrade
Repurchase of Common Stock
------0.16
Upgrade
Other Financing Activities
-1.13-1.25-0.66-0.42-0.06-2.64
Upgrade
Financing Cash Flow
8.019.33.735.121.9528.21
Upgrade
Net Cash Flow
-0.441.27-6.26-5.51-8.5415.82
Upgrade
Free Cash Flow
-8.46-8.03-9.99-10.63-10.48-12.39
Upgrade
Free Cash Flow Margin
--13848.28%-2093.50%-786.32%-1032.71%-8544.14%
Upgrade
Free Cash Flow Per Share
-1.98-2.93-7.07-9.00-9.29-18.37
Upgrade
Levered Free Cash Flow
-5.42-5.43-6.03-6.34-5.81-7.02
Upgrade
Unlevered Free Cash Flow
-5.42-5.43-6.03-6.34-5.81-7.02
Upgrade
Change in Working Capital
-0.71-1.220.13-0.21-0.060.13
Upgrade
Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q